Ventas (VTR) Projected to Post Quarterly Earnings on Thursday

Ventas (NYSE:VTR) is anticipated to announce its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.89 per share and revenue of $1.5325 billion for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR) last released its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the previous year, the company posted $0.80 EPS. The business’s quarterly revenue was up 20.5% compared to the same quarter last year. On average, analysts expect Ventas to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Ventas Stock Down 0.1%

Shares of VTR stock opened at $75.88 on Thursday. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01. Ventas has a 12 month low of $58.72 and a 12 month high of $81.89. The stock has a market cap of $35.64 billion, a P/E ratio of 145.92, a P/E/G ratio of 1.88 and a beta of 0.78. The company has a 50 day simple moving average of $78.30 and a two-hundred day simple moving average of $72.62.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Wednesday, December 31st. Ventas’s payout ratio is currently 369.23%.

Analyst Ratings Changes

Several research analysts have recently commented on VTR shares. KeyCorp raised their price objective on Ventas from $70.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Jefferies Financial Group restated a “buy” rating and set a $93.00 target price on shares of Ventas in a research note on Monday, December 15th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, January 5th. Finally, The Goldman Sachs Group began coverage on shares of Ventas in a research report on Friday, January 9th. They set a “buy” rating and a $94.00 price objective on the stock. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $81.63.

Insider Buying and Selling at Ventas

In other news, CEO Peter J. Bulgarelli sold 2,229 shares of the firm’s stock in a transaction dated Wednesday, November 19th. The stock was sold at an average price of $80.08, for a total transaction of $178,498.32. Following the completion of the transaction, the chief executive officer owned 106,488 shares in the company, valued at $8,527,559.04. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.26, for a total value of $797,477.72. Following the completion of the sale, the chief executive officer owned 1,145,695 shares in the company, valued at $88,516,395.70. This represents a 0.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 176,747 shares of company stock worth $13,579,533. Insiders own 1.00% of the company’s stock.

Institutional Trading of Ventas

A number of large investors have recently added to or reduced their stakes in the company. NewEdge Advisors LLC increased its stake in Ventas by 250.9% during the third quarter. NewEdge Advisors LLC now owns 5,926 shares of the real estate investment trust’s stock worth $415,000 after acquiring an additional 4,237 shares during the last quarter. Lido Advisors LLC lifted its stake in shares of Ventas by 43.3% in the 3rd quarter. Lido Advisors LLC now owns 6,047 shares of the real estate investment trust’s stock valued at $426,000 after purchasing an additional 1,828 shares during the last quarter. Flow Traders U.S. LLC purchased a new position in shares of Ventas in the 3rd quarter worth approximately $316,000. Brooklyn Investment Group boosted its holdings in shares of Ventas by 24.4% in the 3rd quarter. Brooklyn Investment Group now owns 2,921 shares of the real estate investment trust’s stock worth $204,000 after purchasing an additional 572 shares during the period. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA increased its position in shares of Ventas by 15.3% during the 3rd quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 2,330 shares of the real estate investment trust’s stock valued at $163,000 after purchasing an additional 310 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.